The FDA raised concerns about the health effects of MDMA for PTSD treatment due to bias in studies and potential cardiovascular risks like increased blood pressure and pulse rates.
Approval of MDMA for therapy would signify a significant change in the perception and regulation of psychedelic compounds, with potential benefits for PTSD patients lacking effective treatments.
[
add
]
[
|
|
...
]